Science Explorer Back to mapMap
Discussion
Company · Somerville · United States

Finch Therapeutics (United States)

finchtherapeutics.comROR OpenAlex
Research works
17
▼ 47% vs 2018-21
Citations
640
38.4 per fractional work
Top-10% rate
11.8%
all institutions 10.0%
Open access
66%
world 40%
International
31%
world 18%
Finch Therapeutics (United States)

Not ranked overall: Finch Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Finch Therapeutics (United States) work in?

In all years, 53% of research at Finch Therapeutics (United States) is in Health Sciences, 42% in Life Sciences. Its largest fields are Medicine (52%), Biochemistry, Genetics and Molecular Biology (33%), Immunology and Microbiology (5%). It does 1.8× the world's share of Life Sciences.

Health Sciences: 9 fractional works · 53.4% of its workMedicine: 9 fractional works · 51.9% of its workInfectious Diseases: 4 fractional works · 22.7% of its workGastroenterology: 1 fractional works · 8.7% of its workEpidemiology: 1 fractional works · 5.6% of its workSurgery: 1 fractional works · 3.9% of its workOncology: 0 fractional works · 2.3% of its workHepatology: 0 fractional works · 2.1% of its workPsychiatry and Mental health: 0 fractional works · 2.0% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 1.1% of its workPhysiology: 0 fractional works · 1.0% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.0% of its workGenetics: 0 fractional works · 0.5% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.3% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.4% of its workHealth Professions: 0 fractional works · 1.5% of its workGeneral Health Professions: 0 fractional works · 1.5% of its workLife Sciences: 7 fractional works · 42.5% of its workBiochemistry, Genetics and Molecular Biology: 5 fractional works · 32.8% of its workMolecular Biology: 4 fractional works · 24.8% of its workGenetics: 1 fractional works · 5.6% of its workCell Biology: 0 fractional works · 1.0% of its workMolecular Medicine: 0 fractional works · 1.0% of its workClinical Biochemistry: 0 fractional works · 0.5% of its workImmunology and Microbiology: 1 fractional works · 4.7% of its workImmunology: 1 fractional works · 3.9% of its workMicrobiology: 0 fractional works · 0.7% of its workApplied Microbiology and Biotechnology: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 3.0% of its workNeurology: 0 fractional works · 2.0% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.0% of its workAgricultural and Biological Sciences: 0 fractional works · 1.6% of its workFood Science: 0 fractional works · 1.6% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.3% of its workPharmacology: 0 fractional works · 0.3% of its workPhysical Sciences: 1 fractional works · 3.4% of its workEnvironmental Science: 0 fractional works · 1.4% of its workEcology: 0 fractional works · 1.2% of its workEnvironmental Chemistry: 0 fractional works · 0.2% of its workComputer Science: 0 fractional works · 1.3% of its workComputer Vision and Pattern Recognition: 0 fractional works · 1.3% of its workEngineering: 0 fractional works · 0.7% of its workAerospace Engineering: 0 fractional works · 0.7% of its workSocial Sciences: 0 fractional works · 0.7% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.7% of its workEconomics and Econometrics: 0 fractional works · 0.7% of its workSocial Sciences: 0 fractional works · 0.1% of its workALL ITS WORKFinchTherapeutics…17fractional works, all years
Life Sciences42%Physical Sciences3%Health Sciences53%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Medicine951.9%
    2. Health Professions01.5%
    1. Biochemistry, Genetics and Molecular Biology532.8%
    2. Immunology and Microbiology14.7%
    3. Neuroscience03.0%
    4. Agricultural and Biological Sciences01.6%
    5. Pharmacology, Toxicology and Pharmaceutics00.3%
    1. Environmental Science01.4%
    2. Computer Science01.3%
    3. Engineering00.7%
    1. Economics, Econometrics and Finance00.7%
    2. Social Sciences00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.21× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 9.47× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 11.72× its world share, 1 worksImmunology and Micro…Neuroscience: 2.12× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.78× its world share, 0 worksPharmacology, Toxico…Medicine: 1.68× its world share, 2 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 11.7×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Immunology and Microbiology11.72×1 works
  2. Biochemistry, Genetics and Molecular Biology9.47×2 works
  3. Pharmacology, Toxicology and Pharmaceutics2.78×0 works
  4. Neuroscience2.12×0 works
  5. Medicine1.68×2 works
  6. Agricultural and Biological Sciences0.21×0 works

Who are the top researchers at Finch Therapeutics (United States)?

Ranked on the quality score, Sonia C. Timberlake lead among researchers whose main affiliation is Finch Therapeutics (United States).

  1. 1 Sonia C. Timberlake United States · #646,421 worldwide 2k citations · 33 works
All ranked researchers at Finch Therapeutics (United States)

What are the most cited papers from Finch Therapeutics (United States)?

The most cited paper from Finch Therapeutics (United States) is "Strain Tracking Reveals the Determinants of Bacterial Engraftment in the Human Gut Following Fecal Microbiota Transplantation" (Christopher S. Smillie, Jenny S. Sauk, Dirk Gevers et al., 2018), with 446 citations. Next come "A library of human gut bacterial isolates paired with longitudinal multiomics data enables mechanistic microbiome research" (435) and "Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients" (319).

Most cited papers
#PaperReleasedCitations
1 Strain Tracking Reveals the Determinants of Bacterial Engraftment in the Human Gut Following Fecal Microbiota Transplantation Christopher S. Smillie, Jenny S. Sauk, Dirk Gevers et al. · Cell Host & Microbe Open access Feb 2018 446
2 A library of human gut bacterial isolates paired with longitudinal multiomics data enables mechanistic microbiome research Mathilde Poyet et al. · Nature Medicine Sep 2019 435
3 Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients Jessica R. Allegretti, Zain Kassam, Benjamin Harvey Mullish et al. · Clinical Gastroenterology and Hepatology Open access 10 Jul 2019 319
4 Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial Jessica R. Allegretti, Zain Kassam, Madeline Carrellas et al. · The American Journal of Gastroenterology 31 Jan 2019 233
5 Long-term Outcomes of Fecal Microbiota Transplantation in Patients With Cirrhosis Jasmohan Singh Bajaj, Andrew Fagan, Edith A. Gavis et al. · Gastroenterology Open access 18 Jan 2019 181
All 62 most cited papers, with filters and sorting

Which research topics does Finch Therapeutics (United States) publish most on?

By volume in 2022-now: Clostridium difficile and Clostridium perfringens research, Gut microbiota and health, Virus-based gene therapy research and CRISPR and Genetic Engineering.

Clostridium difficile and Clostridium perfringens research: 1 fractional worksGut microbiota and health: 0 fractional worksVirus-based gene therapy…0Virus-based gene therapy research: 0 fractional worksCRISPR and Genetic Engin…0CRISPR and Genetic Engineering: 0 fractional worksDrug Transport and Resistance Mechanisms: 0 fractional worksRNA Interference and Gene Delivery: 0 fractional worksImmune Cell Function and…0Immune Cell Function and Interaction: 0 fractional worksvaccines and immunoinformatics approaches: 0 fractional worksGenomics, phytochemicals, and oxidative stress: 0 fractional worksAxon Guidance and Neuronal Signaling: 0 fractional works
Infectious DiseasesMolecular BiologyGeneticsOncology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Clostridium difficile and Clostridium perfringens research Infectious Diseases 1 works
  2. 2 Gut microbiota and health Molecular Biology 0 works
  3. 3 Virus-based gene therapy research Genetics 0 works
  4. 4 CRISPR and Genetic Engineering Molecular Biology 0 works
  5. 5 Drug Transport and Resistance Mechanisms Oncology 0 works
  6. 6 RNA Interference and Gene Delivery Molecular Biology 0 works
  7. 7 Immune Cell Function and Interaction Immunology 0 works
  8. 8 vaccines and immunoinformatics approaches Molecular Biology 0 works
  9. 9 Genomics, phytochemicals, and oxidative stress Molecular Biology 0 works
  10. 10 Axon Guidance and Neuronal Signaling Cellular and Molecular Neuroscience 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available65.5%not open34.5%

World: 40% of research is openly available.

with international co-authors31.4%domestic only68.6%

World: 18% is written across borders.

How has Finch Therapeutics (United States)'s research output changed?

Output in 2022-2025 was 47% lower than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Finch Therapeutics (United States) as a percentage of every work published that year, 0.000021% in 2024.

still counting0.000025%0.000050%0.000075%Finch Therapeutics (United States)0.000042% in 202520102020

Fractional works of Finch Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Somerville

All research institutions in Somerville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Finch Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.